Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4g8c | C6L | Alpha/beta hydrolase fold protein |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4g8c | C6L | Alpha/beta hydrolase fold protein | / | 1.000 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.531 | |
4g8b | HL6 | Alpha/beta hydrolase fold protein | / | 0.526 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.511 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.508 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.504 | |
2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.504 | |
3ipq | 965 | Oxysterols receptor LXR-alpha | / | 0.503 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.503 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.501 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.501 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.500 | |
2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.498 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.497 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.496 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.496 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.494 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.492 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.491 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.491 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.490 | |
3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.490 | |
1pq6 | 965 | Oxysterols receptor LXR-beta | / | 0.489 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.488 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.488 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.488 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.486 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.486 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.485 | |
3oad | LPO | Renin | 3.4.23.15 | 0.485 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.485 | |
2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.484 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.484 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.483 | |
3fzn | D7K | Benzoylformate decarboxylase | 4.1.1.7 | 0.482 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.481 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.481 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.481 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.481 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.480 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.479 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.479 | |
3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.479 | |
4iae | 1DX | Alr2278 protein | / | 0.479 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.479 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.478 | |
1zdw | FLV | Prenyltransferase | / | 0.478 | |
2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.478 | |
2fm0 | M98 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.478 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.478 | |
2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.477 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.476 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.476 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.475 | |
3g70 | A5T | Renin | 3.4.23.15 | 0.475 | |
1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.474 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.474 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.474 | |
4xoq | F42 | Coenzyme F420:L-glutamate ligase | / | 0.474 | |
5std | UNN | Scytalone dehydratase | 4.2.1.94 | 0.474 | |
1dr4 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.473 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.473 | |
3b9l | AZZ | Serum albumin | / | 0.473 | |
3dyq | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.473 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.473 | |
3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.473 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.473 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.473 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.472 | |
3g72 | A6T | Renin | 3.4.23.15 | 0.472 | |
3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.472 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.472 | |
4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.472 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.472 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.471 | |
2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.471 | |
2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.471 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.471 | |
3pqb | VGP | Putative oxidoreductase | / | 0.471 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.471 | |
1nqv | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.470 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.470 | |
1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.470 | |
2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.470 | |
3g4l | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.470 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.470 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.470 | |
4dbs | 0HV | Aldo-keto reductase family 1 member C3 | / | 0.470 | |
4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.470 | |
1el4 | CTZ | Obelin | / | 0.469 | |
1ro9 | 8BR | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.469 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.469 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.469 | |
3jsx | CC2 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.469 | |
4s1i | PLP | Pyridoxal kinase, putative | / | 0.469 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.469 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.468 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.468 | |
2vq7 | NAP | Putative flavin-containing monooxygenase | / | 0.468 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.468 | |
3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.468 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.468 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.468 | |
4kp6 | 1S1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.468 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.467 | |
1zq5 | E04 | Aldo-keto reductase family 1 member C3 | / | 0.467 | |
2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.467 | |
4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.467 | |
2qw8 | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.466 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.466 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.466 | |
5h8t | RTL | Retinol-binding protein 1 | / | 0.466 | |
2jbs | FMN | p-hydroxyphenylacetate 3-hydroxylase, oxygenase component | / | 0.465 | |
2reh | FAD | Nitroalkane oxidase | 1.7.3.1 | 0.465 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
2w4q | CBW | Prostaglandin reductase 2 | 1.3.1.48 | 0.465 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.465 | |
1rdt | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.464 | |
1s3u | TQD | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
1s9d | AFB | Cytohesin-2 | / | 0.464 | |
1s9d | AFB | ADP-ribosylation factor 1 | / | 0.464 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
4mv1 | ADP | Biotin carboxylase | 6.3.4.14 | 0.464 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.464 | |
3ghw | GHW | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
4dk7 | 0KS | Oxysterols receptor LXR-beta | / | 0.463 | |
1dgh | NDP | Catalase | 1.11.1.6 | 0.462 | |
1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.462 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
2iya | ZIO | Oleandomycin glycosyltransferase | / | 0.462 | |
3hbf | MYC | Flavonoid 3-O-glucosyltransferase | 2.4.1 | 0.462 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
3o9l | LPN | Renin | 3.4.23.15 | 0.462 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.462 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.462 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.462 | |
1s36 | CEI | Obelin | / | 0.461 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.461 | |
2fzj | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
2yp0 | OVE | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.461 | |
3c72 | CX1 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.461 | |
3gts | D3M | DdmC | / | 0.461 | |
3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.461 | |
3nxy | D2H | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
3s3v | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.461 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.461 | |
4eil | FOL | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.461 | |
1pl6 | 572 | Sorbitol dehydrogenase | 1.1.1.14 | 0.460 | |
1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.460 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
3arv | SAU | Chitinase A | / | 0.460 | |
3ihg | VAK | Aklavinone 12-hydroxylase RdmE | / | 0.460 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.460 | |
4n3r | 2GU | Tankyrase-1 | 2.4.2.30 | 0.460 | |
1h69 | ARH | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.459 | |
1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.459 | |
3hu2 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.459 | |
3imx | B84 | Glucokinase | 2.7.1.2 | 0.459 | |
3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.459 | |
4ap1 | NAP | Steroid monooxygenase | / | 0.459 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.458 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.458 | |
3a1l | 2CC | Cytochrome P450 | / | 0.458 | |
3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.458 | |
3p5s | AVU | CD38 molecule | / | 0.458 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.458 | |
3pz3 | PZ3 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.458 | |
4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.458 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2g0g | SP0 | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.457 | |
3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.457 | |
3k1w | BFX | Renin | 3.4.23.15 | 0.457 | |
3nwl | NDP | Catalase | 1.11.1.6 | 0.457 | |
3szf | DCQ | Sulfide-quinone reductase | / | 0.457 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.457 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.457 | |
4std | BFS | Scytalone dehydratase | 4.2.1.94 | 0.457 | |
1crb | RTL | Retinol-binding protein 1 | / | 0.456 | |
2g26 | 3LG | Renin | 3.4.23.15 | 0.456 | |
2h44 | 7CA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.456 | |
2r6j | NDP | Eugenol synthase 1 | 1.1.1.318 | 0.456 | |
2r86 | ATP | 5-formaminoimidazole-4-carboxamide-1-(beta)-D-ribofuranosyl 5'-monophosphate synthetase | / | 0.456 | |
2vt4 | P32 | Beta-1 adrenergic receptor | / | 0.456 | |
3d73 | NBB | Pheromone-binding protein ASP1 | / | 0.456 | |
3ggs | 2FD | Purine nucleoside phosphorylase | 2.4.2.1 | 0.456 | |
3mjr | AC2 | Deoxycytidine kinase | 2.7.1.74 | 0.456 | |
3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
3v94 | WYQ | Phosphodiesterase | / | 0.456 | |
4imu | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.456 | |
4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.456 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
1e7a | PFL | Serum albumin | / | 0.455 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.455 | |
1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.455 | |
2c9d | PHR | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.455 | |
2xvv | 9DN | Serum albumin | / | 0.455 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
3h4v | DVP | Pteridine reductase 1 | 1.5.1.33 | 0.455 | |
3ntz | 3TZ | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
3oag | LPQ | Renin | 3.4.23.15 | 0.455 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.455 | |
3q2m | CKI | Spectinomycin phosphotransferase | / | 0.455 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.455 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.454 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
3owx | XRA | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.454 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.454 | |
3u8d | U8D | Phospholipase A2, membrane associated | / | 0.454 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.454 | |
4gr9 | 372 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.454 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.454 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.454 | |
1pd8 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
2zu9 | GDP | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.453 | |
3aos | JH2 | Hemolymph juvenile hormone binding protein | / | 0.453 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.453 | |
3hxe | BD8 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.453 | |
3nu0 | 3TU | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
3nxv | D2F | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
4xbf | FAD | Lysine-specific histone demethylase 1A | 1 | 0.453 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.453 | |
5d6l | CAU | Beta-2 adrenergic receptor | / | 0.453 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.452 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.452 | |
2g1n | 1IG | Renin | 3.4.23.15 | 0.452 | |
2mm3 | CHO | Gastrotropin | / | 0.452 | |
2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.452 | |
2yej | XQK | Heat shock protein HSP 90-alpha | / | 0.452 | |
3akm | 11D | Fatty acid-binding protein, intestinal | / | 0.452 | |
3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.452 | |
4bfy | ZVY | Pantothenate kinase | 2.7.1.33 | 0.452 | |
4kq6 | DLZ | 6,7-dimethyl-8-ribityllumazine synthase | / | 0.452 | |
5bn4 | ANP | V-type ATP synthase alpha chain | / | 0.452 | |
1kmv | LII | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.451 | |
1osv | CHC | Bile acid receptor | / | 0.451 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.451 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.451 | |
2g22 | 6IG | Renin | 3.4.23.15 | 0.451 | |
2g27 | 4LG | Renin | 3.4.23.15 | 0.451 | |
2gpj | FAD | Siderophore-interacting protein | / | 0.451 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
3c1t | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.451 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
4cdm | FO1 | Deoxyribodipyrimidine photolyase | / | 0.451 | |
4jsi | Q05 | Nitric oxide synthase, brain | 1.14.13.39 | 0.451 | |
5mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.451 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.451 | |
1kw6 | BPY | Biphenyl-2,3-diol 1,2-dioxygenase | 1.13.11.39 | 0.450 | |
1qjg | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.450 | |
1siq | FAD | Glutaryl-CoA dehydrogenase, mitochondrial | 1.3.8.6 | 0.450 | |
3hfb | ML4 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.450 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.450 | |
3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
3vmm | P0D | Alanine--anticapsin ligase | / | 0.450 | |
4boe | CLR | Japanin | / | 0.450 | |
4f0r | MTA | 5-methylthioadenosine/S-adenosylhomocysteine deaminase | / | 0.450 | |
4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.450 | |
5kp2 | COA | 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2 | / | 0.450 | |
1hfr | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
1p33 | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.449 | |
2g1r | 3IG | Renin | 3.4.23.15 | 0.449 | |
2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.449 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.449 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.449 | |
4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.449 | |
5c1m | CLR | Mu-type opioid receptor | / | 0.449 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.449 | |
1rkp | IBM | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.448 | |
1u1d | 181 | Uridine phosphorylase | 2.4.2.3 | 0.448 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2jl1 | NAP | Triphenylmethane reductase | / | 0.448 | |
2uyh | SAH | Modification methylase HhaI | 2.1.1.37 | 0.448 | |
2ykj | YKJ | Heat shock protein HSP 90-alpha | / | 0.448 | |
3gam | MXX | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.448 | |
3gjw | GJW | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.448 | |
3gyf | 51P | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.448 | |
4b66 | NAP | L-ornithine N(5)-monooxygenase | / | 0.448 | |
4bvn | P32 | Beta-1 adrenergic receptor | / | 0.448 | |
4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.448 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.448 | |
4keb | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
4qzu | RTL | Retinol-binding protein 2 | / | 0.448 | |
5d1b | TSN | Histone deacetylase 8 | 3.5.1.98 | 0.448 | |
5fd8 | A5A | Putative carboxypeptidase yocD | / | 0.448 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.448 | |
1kw8 | BPY | Biphenyl-2,3-diol 1,2-dioxygenase | 1.13.11.39 | 0.447 | |
1s7g | NAD | NAD-dependent protein deacylase 2 | / | 0.447 | |
1sjw | NGV | Nogalonic acid methyl ester cyclase | / | 0.447 | |
1x8l | OXR | Retinol dehydratase | / | 0.447 | |
1ygj | RMC | Pyridoxal kinase | 2.7.1.35 | 0.447 | |
2a3b | CFF | Endochitinase B1 | 3.2.1.14 | 0.447 | |
3c14 | FOK | Adenylate cyclase type 2 | / | 0.447 | |
3c14 | FOK | Adenylate cyclase type 5 | / | 0.447 | |
3dge | ADP | Sensor histidine kinase | / | 0.447 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.447 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.447 | |
3nn6 | HNK | 6-hydroxy-L-nicotine oxidase | / | 0.447 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.447 | |
3tfu | PL8 | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 2.6.1.62 | 0.447 | |
3wi2 | P98 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
3zku | HCV | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.447 | |
4gts | 7TP | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.447 | |
4j8t | DOG | Uncharacterized PhzA/B-like protein PA3332 | / | 0.447 | |
4m6l | 21V | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1kms | LIH | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
1rzu | ADP | Glycogen synthase 1 | 2.4.1.21 | 0.446 | |
1ygk | RRC | Pyridoxal kinase | 2.7.1.35 | 0.446 | |
2esd | NAP | NADP-dependent glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.9 | 0.446 | |
2fs4 | PZ1 | Renin | 3.4.23.15 | 0.446 | |
2vtd | LKM | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.446 | |
2x9v | TMQ | Pteridine reductase | / | 0.446 | |
2z7g | EH9 | Adenosine deaminase | 3.5.4.4 | 0.446 | |
3akz | GSU | Glutamate--tRNA ligase 2 | / | 0.446 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
4b14 | 4XB | Glycylpeptide N-tetradecanoyltransferase | / | 0.446 | |
4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.446 | |
4kln | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.446 | |
4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.446 | |
2rh1 | CAU | Beta-2 adrenergic receptor | / | 0.446 | |
1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.445 | |
1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.445 | |
1xdd | AAY | Integrin alpha-L | / | 0.445 | |
2c9z | QUE | Anthocyanidin 3-O-glucosyltransferase 2 | 2.4.1.115 | 0.445 | |
2dhf | DZF | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
2ejz | SAH | Diphthine synthase | / | 0.445 | |
2f98 | NGV | Aklanonic acid methyl ester cyclase AcmA | 5.5.1.23 | 0.445 | |
2i9k | SAH | Modification methylase HhaI | 2.1.1.37 | 0.445 | |
2jfh | LK1 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.445 | |
2zi5 | 3L1 | Deoxycytidine kinase | 2.7.1.74 | 0.445 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.445 | |
3hyw | DCQ | Sulfide-quinone reductase | / | 0.445 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
3myt | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.445 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.445 | |
4bfs | ZVS | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.445 | |
5d5b | CAU | Beta-2 adrenergic receptor | / | 0.445 | |
1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.444 | |
1mxt | FAE | Cholesterol oxidase | 1.1.3.6 | 0.444 | |
1tw2 | ERT | Carminomycin 4-O-methyltransferase DnrK | 2.1.1.292 | 0.444 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.444 | |
1ve3 | SAM | Uncharacterized protein | / | 0.444 | |
2jj2 | ANP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.444 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
2zs9 | ADP | Pantothenate kinase | 2.7.1.33 | 0.444 | |
3hu1 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.444 | |
3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3nxr | D2D | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1gzu | NMN | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 | 2.7.7.1 | 0.443 | |
1i05 | LTL | Major urinary protein 6 | / | 0.443 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
1r8q | AFB | Cytohesin-2 | / | 0.443 | |
1r8q | AFB | ADP-ribosylation factor 1 | / | 0.443 | |
1txt | CAA | HMG-CoA synthase | / | 0.443 | |
1xuo | LA1 | Integrin alpha-L | / | 0.443 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.443 | |
3aiq | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase 1b, chloroplastic | 3.2.1.182 | 0.443 | |
3bl7 | DD1 | m7GpppX diphosphatase | 3.6.1.59 | 0.443 | |
3blo | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.443 | |
3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
3eku | CY9 | Actin-5C | / | 0.443 | |
3gi2 | GHW | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
3hf8 | ML0 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.443 | |
4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.443 | |
4gtt | 7TQ | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.443 | |
4lrr | CF9 | Thymidylate synthase | / | 0.443 | |
4wh2 | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.443 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.443 | |
1drf | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1enp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH], chloroplastic | 1.3.1.9 | 0.442 | |
1gt5 | BZQ | Odorant-binding protein | / | 0.442 | |
1rsg | FAD | Polyamine oxidase FMS1 | / | 0.442 | |
1yhj | R6C | Pyridoxal kinase | 2.7.1.35 | 0.442 | |
2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.442 | |
2bkt | RPF | Renin | 3.4.23.15 | 0.442 | |
2bpo | FAD | NADPH--cytochrome P450 reductase | / | 0.442 | |
2d06 | EST | Sulfotransferase 1A1 | 2.8.2.1 | 0.442 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.442 | |
2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
2w3m | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.442 | |
3d76 | NBB | Pheromone-binding protein ASP1 | / | 0.442 | |
3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.442 | |
4ey6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.442 | |
4gtv | 7TR | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.442 | |
4h3f | 10O | Beta-secretase 1 | 3.4.23.46 | 0.442 | |
4k38 | SAM | Anaerobic sulfatase-maturating enzyme | 1.8.98 | 0.442 | |
4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
4zzj | CNA | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.442 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.442 | |
3qak | UKA | Adenosine receptor A2a | / | 0.442 | |
1fmj | RTL | Retinol dehydratase | / | 0.441 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.441 | |
1yw8 | A75 | Methionine aminopeptidase 2 | / | 0.441 | |
2a9z | 26A | Adenosine kinase | 2.7.1.20 | 0.441 | |
2geu | COK | Pantothenate kinase | 2.7.1.33 | 0.441 | |
2oz5 | 7XY | Uncharacterized protein | / | 0.441 | |
3g6z | A7T | Renin | 3.4.23.15 | 0.441 | |
3gdp | FAD | (R)-mandelonitrile lyase 2 | 4.1.2.10 | 0.441 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.441 | |
3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.441 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4lxj | LAN | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.441 | |
4pab | THG | Dimethylglycine dehydrogenase, mitochondrial | 1.5.8.4 | 0.441 | |
1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.440 | |
1q13 | TES | Prostaglandin-E(2) 9-reductase | 1.1.1.189 | 0.440 | |
2a1t | FAD | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.7 | 0.440 | |
2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.440 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.440 | |
2poq | ISD | Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase | 1.3.1.20 | 0.440 | |
2v2z | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.440 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
2xls | FAD | Putative flavin-containing monooxygenase | / | 0.440 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.440 | |
3da2 | 4MD | Carbonic anhydrase 13 | 4.2.1.1 | 0.440 | |
3h3q | H13 | Collagen type IV alpha-3-binding protein | / | 0.440 | |
3l3m | A92 | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.440 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.440 | |
3sgv | 2BJ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.440 | |
3std | MQ0 | Scytalone dehydratase | 4.2.1.94 | 0.440 | |
4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.440 | |
4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.440 | |
4dpd | DHF | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.440 | |
4kfj | 1R0 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.440 | |
4uwm | FMN | 3,6-diketocamphane 1,6 monooxygenase | 1.14.13 | 0.440 |